---
title: "Eliquis (apixaban) in nonvalvular atrial fibrillation: Access and coverage questions"
description: "Access and coverage questions on Eliquis (apixaban) in nonvalvular atrial fibrillation, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and support. Questions: Is there an Eliquis copay card or free trial? How much does Eliquis cost with the copay card? Can patients on Medicare or Medicaid use the Eliquis copay card? Is Eliquis covered by commercial insurance and Medicare Part D? 3 further questions follow. 7 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/access-and-coverage"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Eliquis (apixaban) in nonvalvular atrial fibrillation: Access and coverage questions

Manufacturer: Bristol-Myers Squibb Company; Pfizer Inc  
Prescribing information: [Eliquis](https://packageinserts.bms.com/pi/pi_eliquis.pdf)

## Access and support

<a id="eliquis-copay-card"></a>

### Is there an Eliquis copay card or free trial?

> “Free 30-Day Trial & $10 Co-Pay card* for Eligible Patients^
>
> Free 30-day trial offer for first-time patients and co-pay assistance for eligible patients prescribed ELIQUIS.*
>
>  This co-pay card is accepted only at participating pharmacies
>  This co-pay card is not health insurance
>
> *For commercially insured patients. Annual maximum benefit of $2,000. ^Eligibility and terms and conditions apply.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Free%2030%2DDay%20Trial%20%26%20%2410,and%20terms%20and%20conditions%20apply.)

> “Card must be activated before use. Activation and first use of the Co-pay Card must take place by December 31, 2026. Card expires 24 months from activation. Upon expiration, eligible patients may re-enroll in the Co-pay Card Program.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Card%20must%20be%20activated%20before,in%20the%20Co%2Dpay%20Card%20Program.)

On the page, select: Click here to see Co-pay Card patient eligibility requirements and terms of use

Note: The patient starter guide for atrial fibrillation that the resources page links states a maximum annual benefit of $3,500. The resources page and the co-pay card terms of use state $2,000.

<a id="eliquis-copay-cost"></a>

### How much does Eliquis cost with the copay card?

> “Eligible patients who present an activated Co-pay Card together with a valid prescription for ELIQUIS at participating pharmacies may pay as little as $10 for a 30-day supply or $10 for their first 90-day supply of ELIQUIS while enrolled in the program. Patients may pay as little as $30 for subsequent 90-day refills for up to 24 months. Program benefit is subject to a maximum annual benefit of $2,000.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Eligible%20patients%20who%20present%20an,maximum%20annual%20benefit%20of%20%242%2C000.)

On the page, select: Click here to see Co-pay Card patient eligibility requirements and terms of use

> “Offer not applicable to co-pays of $10 or less.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Offer%20not%20applicable%20to%20co%2Dpays%20of%20%2410%20or%20less.)

On the page, select: Click here to see Co-pay Card patient eligibility requirements and terms of use

> “*For commercially insured patients. Annual maximum benefit of $2,000.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=%2AFor%20commercially%20insured%20patients.%20Annual%20maximum%20benefit%20of%20%242%2C000.)

Note: The patient starter guide for atrial fibrillation that the resources page links states a maximum annual benefit of $3,500. The co-pay card terms of use quoted here state $2,000 and require activation by December 31, 2026.

<a id="eliquis-copay-medicare"></a>

### Can patients on Medicare or Medicaid use the Eliquis copay card?

> “You may be eligible for the Co-pay Card for ELIQUIS<sup>®</sup> (apixaban) if:
>
> You are insured by commercial insurance and your prescription insurance coverage does not cover the full cost of your prescription, that is, you have a co-pay obligation for ELIQUIS;
> You do not have prescription insurance coverage through a state or federal healthcare program, including but not limited to Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), or Department of Defense (DOD) programs; patients who move from commercial plans to state or federal healthcare programs will no longer be eligible;
> You are a resident of the United States, Puerto Rico, or other select U.S. Territory.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=You%20may%20be%20eligible%20for,or%20other%20select%20U.S.%20Territory.)

On the page, select: Click here to see Co-pay Card patient eligibility requirements and terms of use

<a id="eliquis-insurance-coverage"></a>

### Is Eliquis covered by commercial insurance and Medicare Part D?

> “Over 90% of patients nationwide with commercial or Medicare Standard Part D
> coverage have access to ELIQUIS<sup>†</sup>”

Source: [ELIQUIS: Formulary Coverage Lookup, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/formulary-lookup#:~:text=Over%2090%25%20of%20patients%20nationwide,coverage%20have%20access%20to)

Note: The page attributes the figure to Fingertip Formulary and does not define access; the as-of date it displays matched the capture date, so it is not quoted.

<a id="eliquis-benefits-support"></a>

### Is there an Eliquis reimbursement support program?

> “Our live specialists are just a phone call away and
> ready to help you and your patients at
>
> 1-855-ELIQUIS (354-7847)
>
> Monday–Friday, 8 AM–8 PM ET.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Our%20live%20specialists%20are%20just,Monday%E2%80%93Friday%2C%208%20AM%E2%80%938%20PM%20ET.)

> “Patients can also contact their Healthcare
> Provider to request completion of a Benefits
> Review Form so our live specialists can confirm plan
> coverage, estimate out-of-pocket expenses,
> help with prior authorizations, formulary and tiering exceptions.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Patients%20can%20also%20contact%20their,authorizations%2C%20formulary%20and%20tiering%20exceptions.)

> “Reimbursement Services Program for ELIQUIS
>
> 1-855-ELIQUIS [354-7847]
> Monday-Friday, 8 AM to 8 PM ET
> Benefit Review”

Source: [ELIQUIS: Formulary Coverage Lookup, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/formulary-lookup#:~:text=Reimbursement%20Services%20Program%20for%20ELIQUIS,Benefit%20Review)

<a id="eliquis-medicare-cost-support"></a>

### What Medicare programs can help with Eliquis costs?

> “Beginning in 2027, the maximum out-of-pocket amount you pay for covered Medicare Part D 
> drugs, including your yearly deductible, is now $2,400. Once this amount is reached, you will 
> pay $0 for the rest of the year. There is no longer a coverage gap phase.”

Source: [ELIQUIS: ELIQUIS-NVAF-Starter-Guide-iPDF.pdf, page 4, captured 2026-11-12](https://www.eliquis.com/assets/buildeasy/us-commercial/eliquis-hcp/en/resources/pdf/ELIQUIS-NVAF-Starter-Guide-iPDF.pdf#page=4)

> “Extra Help, also known as Low-Income Subsidy (LIS), is a Medicare program that helps 
> people with limited income and resources to pay for Medicare Part D prescription drug 
> plan coverage premiums, deductibles, coinsurance, and other costs. Some people are 
> automatically enrolled in Extra Help, and others have to apply.”

Source: [ELIQUIS: ELIQUIS-NVAF-Starter-Guide-iPDF.pdf, page 4, captured 2026-11-12](https://www.eliquis.com/assets/buildeasy/us-commercial/eliquis-hcp/en/resources/pdf/ELIQUIS-NVAF-Starter-Guide-iPDF.pdf#page=4)

> “The MPPP helps spread out your yearly Medicare drug expenses
> The MPPP enables patients to:
> Pay out-of-pocket costs* in monthly payments
> Owe $0 at the pharmacy”

Source: [ELIQUIS: ELIQUIS-NVAF-Starter-Guide-iPDF.pdf, page 5, captured 2026-11-12](https://www.eliquis.com/assets/buildeasy/us-commercial/eliquis-hcp/en/resources/pdf/ELIQUIS-NVAF-Starter-Guide-iPDF.pdf#page=5)

> “MPPP is offered by Medicare Part D. Anyone with a Medicare Part D prescription drug plan 
> or Medicare health plan with medication coverage is able to enroll and use this payment 
> option for prescription medications.”

Source: [ELIQUIS: ELIQUIS-NVAF-Starter-Guide-iPDF.pdf, page 5, captured 2026-11-12](https://www.eliquis.com/assets/buildeasy/us-commercial/eliquis-hcp/en/resources/pdf/ELIQUIS-NVAF-Starter-Guide-iPDF.pdf#page=5)

Note: The passages are from the patient starter guide for atrial fibrillation that the resources page links. They describe Medicare Part D provisions. Patients with Medicare Part D coverage are ineligible for the Eliquis Co-pay Card.

<a id="eliquis-samples"></a>

### Are Eliquis samples available for prescribers?

> “Samples of ELIQUIS 2.5 mg and 5 mg tablets are available for eligible prescribers.”

Source: [ELIQUIS: Patient & Physician Resources, captured 2026-11-12](https://www.eliquis.com/eliquis/hcp/resources#:~:text=Samples%20of%20ELIQUIS%202.5%20mg,are%20available%20for%20eligible%20prescribers.)

## Related pages
- [Medical information: Eliquis (apixaban): Nonvalvular atrial fibrillation](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation)
- [Indication](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/safety)
- [Specific populations](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/storage-and-supply)
